{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:34:44Z","timestamp":1787495684336,"version":"build-2736575974"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA112243, R01CA112243-05S1, R33CA10704339"],"award-info":[{"award-number":["R01CA112243, R01CA112243-05S1, R33CA10704339"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA112524, R01CA112524-05S2,U01CA83180"],"award-info":[{"award-number":["R01CA112524, R01CA112524-05S2,U01CA83180"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA098438"],"award-info":[{"award-number":["R01CA098438"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016086, P30CA008748, P30CA014089, P30CA118100"],"award-info":[{"award-number":["P30CA016086, P30CA008748, P30CA014089, P30CA118100"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA093459"],"award-info":[{"award-number":["P50 CA093459"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The University of Texas MD Anderson Cancer Center Various Donors Melanoma and Skin Cancers Priority Program Fund"},{"name":"the Miriam and Jim Mulva Research Fund"},{"name":"the McCarthy Skin Cancer Research Fund and the Marit Peterson Fund for Melanoma Research"},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES010126"],"award-info":[{"award-number":["P30ES010126"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"a University of Sydney Medical Foundation Program grant and a Michael Smith Foundation for Health Research Infrastructure Award"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174234","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T19:09:09Z","timestamp":1490123349000},"page":"e0174234","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-8628","authenticated-orcid":true,"given":"Li","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Kanetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Berwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the GEM Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"36","key":"ref2","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"CM Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/carcin\/bgv157","article-title":"Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study","volume":"37","author":"I Orlow","year":"2016","journal-title":"Carcinogenesis"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/pcmr.12437","article-title":"Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival","volume":"29","author":"J Yin","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"issue":"32","key":"ref5","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1200\/JCO.2009.22.1135","article-title":"Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma","volume":"27","author":"JA Newton-Bishop","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"e0126394","DOI":"10.1371\/journal.pone.0126394","article-title":"Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness","volume":"10","author":"C Wyatt","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"ref7","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1093\/hmg\/ddr415","article-title":"Genome-wide association study identifies novel loci predisposing to cutaneous melanoma","volume":"20","author":"CI Amos","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ije\/dyl044","article-title":"A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma","volume":"35","author":"CB Begg","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ijc.26023","article-title":"Vitamin D receptor polymorphisms in patients with cutaneous melanoma","volume":"130","author":"I Orlow","year":"2012","journal-title":"Int J Cancer"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1158\/1055-9965.EPI-14-0431","article-title":"Sun exposure and melanoma survival: a GEM study","volume":"23","author":"M Berwick","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref11","article-title":"Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies","author":"DA Jolliffe","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"KK Deeb","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"D Feldman","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.genom.9.081307.164242","article-title":"Genotype imputation","volume":"10","author":"Y Li","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random Survival Forests","volume":"2","author":"H Ishwaran","year":"2008","journal-title":"Annals of Applied Statistics"},{"issue":"489","key":"ref16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1198\/jasa.2009.tm08622","article-title":"High-Dimensional Variable Selection for Survival Data","volume":"105","author":"H Ishwaran","year":"2010","journal-title":"Journal of the American Statistical Association"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1214\/10-STS321","article-title":"Identification, Inference and Sensitivity Analysis for Causal Mediation Effects","volume":"25","author":"K Imai","year":"2010","journal-title":"Stat Sci"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/a0020761","article-title":"A General Approach to Causal Mediation Analysis","volume":"15","author":"K Imai","year":"2010","journal-title":"Psychol Methods"},{"issue":"1","key":"ref19","first-page":"289","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"L Breiman","year":"2001","journal-title":"Machine Learning"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"303250","DOI":"10.1155\/2015\/303250","article-title":"Risk Prediction of One-Year Mortality in Patients with Cardiac Arrhythmias Using Random Survival Forest","volume":"2015","author":"F Miao","year":"2015","journal-title":"Comput Math Methods Med"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/aje\/kwh120","article-title":"Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?","volume":"159","author":"T Dwyer","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"e101507","DOI":"10.1371\/journal.pone.0101507","article-title":"Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance","volume":"9","author":"LA Penn","year":"2014","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/1471-2407-13-406","article-title":"MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study","volume":"13","author":"AE Cust","year":"2013","journal-title":"BMC Cancer"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1158\/1078-0432.CCR-15-2066","article-title":"The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis","volume":"22","author":"M Vogelsang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1479-5876-11-279","article-title":"Melanoma risk loci as determinants of melanoma recurrence and survival","volume":"11","author":"J Rendleman","year":"2013","journal-title":"J Transl Med"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1096\/fj.12-208975","article-title":"In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1","volume":"26","author":"AT Slominski","year":"2012","journal-title":"FASEB J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsbmb.2014.11.010","article-title":"Novel activities of CYP11A1 and their potential physiological significance","volume":"151","author":"AT Slominski","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1038\/srep14875","article-title":"Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland","volume":"5","author":"AT Slominski","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1096\/fj.13-242040","article-title":"RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D","volume":"28","author":"AT Slominski","year":"2014","journal-title":"FASEB J"},{"key":"ref31","article-title":"Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORalpha and RORgamma","author":"AT Slominski","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"39","key":"ref32","doi-asserted-by":"crossref","first-page":"63261","DOI":"10.18632\/oncotarget.11211","article-title":"RORalpha and RORgamma expression inversely correlates with human melanoma progression","volume":"7","author":"AA Brozyna","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.humpath.2010.09.014","article-title":"Expression of vitamin D receptor decreases during progression of pigmented skin lesions","volume":"42","author":"AA Brozyna","year":"2011","journal-title":"Hum Pathol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.humpath.2012.03.031","article-title":"Expression of the vitamin D-activating enzyme 1alpha-hydroxylase (CYP27B1) decreases during melanoma progression","volume":"44","author":"AA Brozyna","year":"2013","journal-title":"Hum Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T21:40:07Z","timestamp":1568929207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174234"}},"subtitle":[],"editor":[{"given":"Andrzej T.","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174234","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}